Search Menu
Photonics Media Photonics Buyers' Guide Photonics Spectra BioPhotonics EuroPhotonics Vision Spectra Photonics Showcase Photonics ProdSpec Photonics Handbook
More News

Deisseroth, Miesenböck, Boyden win award for optogenetics advances

Facebook Twitter LinkedIn Email Comments
Professors Karl Deisseroth of Stanford University, Gero Miesenböck of the University of Oxford and Edward S. Boyden of MIT have been awarded Brandeis University’s 16th annual Jacob Heskel Gabbay Award in Biotechnology and Medicine.

The researchers were honored for their contributions to the discovery and applications of optogenetics. Hundreds of labs have started using the technique to manipulate brain activity in experimental animals, exploring the neurobiology of phenomena such as decision making and neurodegenerative diseases. The technique is expected to have a significant impact on President Obama’s brain initiative.

The award was created by the Jacob and Louise Gabbay Foundation and is given in recognition of scientists in academia, medicine or industry whose work has outstanding scientific content and significant practical consequences in the biomedical sciences. “The history of science suggests that most scientific revolutions are sparked by advances in practical areas, such as instrumentation and techniques,” the foundation said in a statement. “This year’s honorees exemplify the spirit of this award in that their laboratory observations have led to significant practical consequences.”

The award consists of a $15,000 cash prize (to be shared in the case of multiple winners) and a medallion.

This year’s symposium will take place Thursday, Oct. 10, at 3:30 p.m. in the Shapiro Campus Center theater at Brandeis in Boston. The talks are free and open to the public.

For more information, visit:

Jul 2013
A discipline that combines optics and genetics to enable the use of light to stimulate and control cells in living tissue, typically neurons, which have been genetically modified to respond to light. Only the cells that have been modified to include light-sensitive proteins will be under control of the light. The ability to selectively target cells gives researchers precise control. Using light to control the excitation, inhibition and signaling pathways of specific cells or groups of...
AmericasBiophotonicsBrandeis UniversityBusinessEdward S. BoydenEuropeGero MiesenböckKarl DeisserothMITopticsoptogeneticsRapidScanStanford UniversityUniversity of Oxfordlasers

back to top
Facebook Twitter Instagram LinkedIn YouTube RSS
©2019 Photonics Media, 100 West St., Pittsfield, MA, 01201 USA,

Photonics Media, Laurin Publishing
x Subscribe to BioPhotonics magazine - FREE!
We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.